2016
DOI: 10.1021/acs.bioconjchem.6b00034
|View full text |Cite
|
Sign up to set email alerts
|

Universal Molecular Scaffold for Facile Construction of Multivalent and Multimodal Imaging Probes

Abstract: Multivalent and multimodal imaging probes are rapidly emerging as powerful chemical tools for visualizing various biochemical processes. Herein, we described a bifunctional chelator (BFC)-based scaffold that can be used to construct such promising probes concisely. Compared to other reported similar scaffolds, this new BFC scaffold demonstrated two major advantages: (1) significantly simplified synthesis due to the use of this new BFC that can serve as chelator and linker simultaneously; (2) highly effcient sy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 24 publications
(56 reference statements)
0
17
0
Order By: Relevance
“…[9][10][11][12][13] However, the widespread applications of such promising probes in biomedicine are heavily hampered as introducing different functional molecules into the molecular platform usually involves abundant and complex chemistry including multiple synthetic steps, tedious chromatographic separations, and issues of chemo-selectivity. [14][15][16][17] Hence, continuous efforts should be made to design simple uorophores with intrinsic multifunctional ability, which have high signicance and direct impact on the eld of uorescence imaging and biomedicine. 18,19 Over the past several years, uorescence based imaging in the second near-infrared channel (NIR-II, 1000-1700 nm) has gained attention for its prominent merits and surpasses the conventional visible/NIR-I channels (700-900 nm) in terms of lower tissue scattering and minimal auto-uorescence, thus leading to signicant advances in imaging qualities including image depth and spatiotemporal resolution.…”
Section: Introductionmentioning
confidence: 99%
“…[9][10][11][12][13] However, the widespread applications of such promising probes in biomedicine are heavily hampered as introducing different functional molecules into the molecular platform usually involves abundant and complex chemistry including multiple synthetic steps, tedious chromatographic separations, and issues of chemo-selectivity. [14][15][16][17] Hence, continuous efforts should be made to design simple uorophores with intrinsic multifunctional ability, which have high signicance and direct impact on the eld of uorescence imaging and biomedicine. 18,19 Over the past several years, uorescence based imaging in the second near-infrared channel (NIR-II, 1000-1700 nm) has gained attention for its prominent merits and surpasses the conventional visible/NIR-I channels (700-900 nm) in terms of lower tissue scattering and minimal auto-uorescence, thus leading to signicant advances in imaging qualities including image depth and spatiotemporal resolution.…”
Section: Introductionmentioning
confidence: 99%
“…Another chemical tool MeTz‐NOTA‐RGD was prepared using our previously developed bifunctional NOTA chelator [ 33 ] via a multiple step synthetic scheme (Scheme S1, Supporting Information). Briefly, using commercially available NH 2 ‐PEG 3 ‐NH(Boc), N 3 ‐NOTA(tBu)‐COOH was first converted to N 3 ‐NOTA(tBu)‐PEG 3 ‐NH(Boc), which was then conjugated with RGD‐PEG 4 ‐BCN to give RGD‐PEG 4 ‐NOTA(tBu)‐PEG 3 ‐NH(Boc).…”
Section: Resultsmentioning
confidence: 99%
“…was developed by Zeng's group (8). Unlike (HBED-CC) TFP 2 , which possesses two identical reactive groups, N 3 -NO t B 2 contains two different reactive groups including an N 3 group for click chemistry and a COOH group for amide coupling, offering selectivity for conjugation with two different peptides.…”
Section: Peptide-based Agentsmentioning
confidence: 99%
“…Another recent example is the RGD-AE105 heterodimer that was prepared by Gai et al, using the BFC framework N 3 -NO t B 2 (8). The prepared RGD-AE105 tracer targets both the integrin a v b 3 and the urokinase-type plasminogen activator receptor simultaneously.…”
Section: Peptide-based Agentsmentioning
confidence: 99%